Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 7,102 | 3,840 | 5,577 | 5,741 | 6,671 |
| Operating Income | -7,102 | -3,840 | -5,577 | -5,741 | -6,671 |
| Other Income | 353 | -36 | 281 | 264 | 196 |
| Pre-tax Income | -6,749 | -3,876 | -5,296 | -5,477 | -6,475 |
| Income Tax | 6 | -7 | 42 | N/A | N/A |
| Net Income Continuous | -6,755 | -3,869 | -5,338 | -5,477 | -6,475 |
| Net Income | $-6,741 | $-3,883 | $-5,338 | $-5,477 | $-6,475 |
| EPS Basic Total Ops | -5.17 | -3.39 | -4.92 | -5.05 | -5.58 |
| EPS Basic Continuous Ops | -5.18 | -3.38 | -4.92 | -5.05 | -5.73 |
| EPS Diluted Total Ops | -5.17 | -3.39 | -4.92 | -5.05 | -5.58 |
| EPS Diluted Continuous Ops | -5.18 | -3.38 | -4.92 | -5.05 | -5.73 |
| EPS Diluted Before Non-Recurring Items | -5.22 | -3.39 | -4.00 | N/A | N/A |
| EBITDA(a) | $-7,097 | $-3,834 | $-5,490 | $-5,748 | $-6,673 |